PEOPLE - Antisoma makes appointment:
This article was originally published in Clinica
Executive Summary
Antisoma, a UK developer of tumour targeting products for cancer therapy and imaging has named Dr Ian Matthews head of peptide chemistry. He was previously laboratory head of the chemistry department at Novartis Pharmaceuticals.